doi:10.1016/s2212-8328(10)80018-9Vijay YewaleDhanya DharmapalanElsevier B.V.Pediatric Infectious DiseaseYewale V, Dharmapalan D. Beta-lactam and beta-lactamase inhibitor combinations. Pediatr Infect Dis. 2010;2:69-76.
Clinical Role of β-Lactam/β-Lactamase Inhibitor Combinations The use of β-lactamase inhibitors in combination with β-lactam antibiotics is currently the most successful strategy to combat a specific resistance mech... N Lee,KY Yuen,CR Kumana - 《Drugs》 被引量: 156发表: 2003年 Treatment wi...
Novel beta-lactam/beta-lactamase inhibitor (BIBLI) combinations are commercially available and have been used for treating carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. Continuous surveillance of susceptibility profiles and resistance mechanism identification are necessary to monitor the evolution...
With some antibiotic-inhibitor combinations, it may be possible to extend the dosage interval if an adequate amount of inhibitor is provided over the course of therapy. 展开 关键词: ANTIBIOTICS DOSAGE SCHEDULES ENZYME INHIBITORS PHARMACODYNAMICS PHARMACOKINETICS RESISTANCE DOI: 10.1016/0926-6917(95)90043...
In summary, ceftolozane/tazobactam and ceftazidime/avibactam are 2 new second-generation cephalosporin/beta-lactamase inhibitor combinations. After appropriate trials are conducted, they may prove useful in the treatment of MDR GNB infections. Antimicrobial stewardship will be essential to preserve the ...
beta-lactam/beta-lactamase inhibitor combinations: from then to now. Ann Pharmacother 2015;49:86-98.Toussaint KA, Gallagher JC. Beta-lactam/beta-lactamase inhibitor combinations: from then to now. Ann Pharmacother. 2015; 49 (1):86–98. doi: 10.1177/1060028014556652. [ Cr...
Beta-lactam antibiotic and beta-lactamase inhibitor combinations. JAMA. 2001;285:386-8.Lee NL, Yuen KY, Kumana CR (2001) Beta-lactam antibiotic and beta-lactamase inhibitor combinations. JAMA 285:386–388Lee, N. L., K. Y. Yuen and C. R. Kumana (2001). "Beta-lactam antibiotic and ...
Introduction: The Role Of Beta-Lactam/ Beta-Lactamase Inhibitor Combinations In Respiratory Tract Infection Guidelines And In Clinical UseRespiratory Tract Infections (RTIs) represent a major cause of illness globally. Although most RTIs are caused by viral infections, some have a significant bacteri...
doi:10.1097/00019048-200202001-00005SuwangoolPanpitInfectious Disease in Clinical PracticeSuwangool,Panpit.Use of [beta]-lactam/[beta]-lactamase inhibitor combinations to treat nosocomial pneumonia. The Pediatric Infectious Disease Journal . 2002
fragilis group have been reported to produce unusual beta-lactamases that are refractory to beta-lactamase inhibitors, none of the cefoxitin-resistant isolates tested in this study were resistant to the beta-lactam-beta-lactamase inhibitor combinations....